Extrastriatal dopaminergic dysfunction in tourette syndrome.
about
Response inhibition and interference control in obsessive-compulsive spectrum disordersEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentAnimal models of tic disorders: a translational perspective.The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase?Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels.Analysis of variance in neuroreceptor ligand imaging studies.Motor-cortical interaction in Gilles de la Tourette syndromeIncreased thalamic gamma band activity correlates with symptom relief following deep brain stimulation in humans with Tourette's syndromeA Review and Update on Tourette Syndrome: Where Is the Field Headed?Dual ameliorative effects of Ningdong granule on dopamine in rat models of Tourette's syndromeSynaptic activity unmasks dopamine D2 receptor modulation of a specific class of layer V pyramidal neurons in prefrontal cortex.Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.Rapid Presentation of Emotional Expressions Reveals New Emotional Impairments in Tourette's Syndrome.Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder.Effect of "jian-pi-zhi-dong decoction" on gamma-aminobutyric Acid in a mouse model of tourette syndrome.Tourette syndrome: evolving concepts.Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging.What patients with gilles de la tourette syndrome should be treated with deep brain stimulation and what is the best target?What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome.Dopamine agonists and pathologic behaviors.Animal Models of Tourette Syndrome-From Proliferation to Standardization.Active inference, evidence accumulation, and the urn taskLevodopa effects on [ (11)C]raclopride binding in the resting human brainDopamine D2 Receptors Modulate Pyramidal Neurons in Mouse Medial Prefrontal Cortex through a Stimulatory G-Protein Pathway.Motor control, habits, complex motor stereotypies, and Tourette syndrome.Dual regulating effects of gastrodin on extracellular dopamine concentration in rats models of Tourette's syndrome.Stress-induced dopamine release in human medial prefrontal cortex--18F-fallypride/PET study in healthy volunteers.Cell-free protein synthesis and purification of human dopamine D2 receptor long isoform.Altered structure of cortical sulci in gilles de la Tourette syndrome: Further support for abnormal brain development.Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.Abnormal cortical and brain stem plasticity in Gilles de la Tourette syndrome.Olfactory functioning in adults with Tourette syndrome.Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative DisordersStriatal dopaminergic alterations in Tourette's syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies
P2860
Q26863507-4225B00E-C5F8-4DBB-B496-27A05917EE7EQ28972478-121474C2-813F-4F07-A2E0-DF86D8A61C38Q30395243-EFC8D61C-F087-473C-B63C-2C17C54C18BEQ30427160-72329DDC-4EB9-46D0-B1AA-1D4112AD9D27Q30435819-47F43AF9-76A5-4495-BED1-D4FE55C4456CQ33652554-E871771D-0272-4EB0-9091-9BA46D949E9CQ33999407-CA04687B-3FF3-4546-B14C-D1E987C4B770Q34124933-93E2D8C4-748D-43AE-86B1-DAEFC65018B4Q34412272-9EE736D2-E1CE-44A4-9346-6CB1762D6DAEQ34516696-23C39F35-BCAF-4EA9-B8FD-7EC9AB755932Q34975245-88FAEA4B-01E5-4B13-B389-3CD05C265B0AQ35961970-5B1E048C-800C-4A54-BAA3-7504F121EE2AQ36075795-46BBACE2-0590-4C8B-828A-C7E16F9B37BAQ36788635-0DD60F03-4AB1-4A39-AD88-BDB967A9BA54Q37154566-BFF7FA18-D7CA-47A1-9188-42470C222B29Q37724959-26369BB7-6472-4EF5-8600-8CEFC007C83CQ37864240-324C5AD0-BEBB-4CA0-8AEC-4892358096F5Q37871233-2A387FB8-FE91-4AE6-AA74-9C240B27D978Q37992506-9540463D-C09C-46F7-9506-7BE267A24E25Q39035125-3EAEE636-6104-4D2C-B4A9-A16F931838ABQ39620073-A5742430-FCB9-4C8B-9137-7DA939EE44A0Q39706145-7B4D406B-C83F-4EE6-91F2-77C80EF41EC9Q40519715-C3661712-9EFF-4F7C-91AB-99474700D6B0Q40730465-3FAD49FD-FA91-44AF-8602-F7A46F613DADQ43508066-D96CB3E4-AB79-479B-BADB-A2F602DF04A8Q43960863-3502882D-8193-40C7-9DBC-E0AE31B9F37CQ45268067-C4DB17BE-A303-4448-B154-38053305D403Q46305702-0CCFE98E-C33D-496A-A268-D1F8F08663A8Q46740445-4D762479-F137-4C5E-8E99-1EB77F4A32BAQ48256714-37794A13-4C21-4EE0-9DCE-04665A3EB674Q48273459-B8B8AF47-08A9-45A1-9474-DEAFC3A834BCQ48886165-415E3A29-870F-4ED8-8930-82FC2AC77B27Q55252475-4281D82A-896F-47F6-A43B-95D2AA87C6D5Q58784650-0BFE7837-26AA-4633-957D-C5713E3CD9EDQ58803617-45F100D0-453A-439C-8B24-951CEA33E798
P2860
Extrastriatal dopaminergic dysfunction in tourette syndrome.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Extrastriatal dopaminergic dysfunction in tourette syndrome.
@en
Extrastriatal dopaminergic dysfunction in tourette syndrome.
@nl
type
label
Extrastriatal dopaminergic dysfunction in tourette syndrome.
@en
Extrastriatal dopaminergic dysfunction in tourette syndrome.
@nl
prefLabel
Extrastriatal dopaminergic dysfunction in tourette syndrome.
@en
Extrastriatal dopaminergic dysfunction in tourette syndrome.
@nl
P2093
P2860
P50
P356
P1433
P1476
Extrastriatal dopaminergic dysfunction in tourette syndrome.
@en
P2093
David M Kideckel
Sylvain Houle
Thomas D L Steeves
P2860
P304
P356
10.1002/ANA.21809
P577
2010-02-01T00:00:00Z